Key result
Graeb score ≥ 4 is linked to a ~4-fold higher risk of symptomatic vasospasm after aSAH.
Why the study?
The modified Fisher scale treats intraventricular hemorrhage as simply present or absent, potentially obscuring meaningful differences in vasospasm risk after aneurysmal subarachnoid hemorrhage.
Does endovascular coiling compared to microsurgical clipping increase the risk of symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage and moderate intraventricular hemorrhage?
Cohort (n=307)
No
Does endovascular coiling compared to microsurgical clipping increase the risk of symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage and moderate intraventricular hemorrhage?
Odds Ratio: 4.32 (95% CI 2.1–8.87)
p-value: p=<0.001
An IVH Graeb score ≥ 4 independently predicts symptomatic vasospasm after aneurysmal SAH, and patients with moderate IVH (Graeb 4-7) may have a higher risk of vasospasm when treated with endovascular coiling compared to microsurgical clipping.
Graeb ≥4 may aid vasospasm risk stratification after aneurysmal SAH; leaves open prospective validation before guiding monitoring or treatment.
Background/Objective: The modified Fisher scale classifies intraventricular hemorrhage (IVH) as present or absent, potentially obscuring meaningful vasospasm risk differences. This study aimed to identify the IVH burden threshold, measured by the Graeb scale, at which symptomatic vasospasm risk increases after aneurysmal subarachnoid hemorrhage (SAH) and whether this association differs by treatment modality. Methods: This retrospective single-center study included aneurysmal SAH patients undergoing microsurgical clipping or endovascular coiling between 2015 and 2025. IVH was graded using the original Graeb scale (range, 0–12) and categorized as no IVH (0), grades 1–3, 4–7, or ≥8. The outcome was symptomatic vasospasm. Multivariate logistic regression and exploratory subgroup analyses were performed. Results: Among the 307 patients analyzed (clipping, n = 224; coiling, n = 83), symptomatic vasospasm occurred in 63 (20.5%). On multivariate analysis, an IVH Graeb score ≥ 4 was the only independent predictor of symptomatic vasospasm (odds ratio, 4.32; 95% confidence interval, 2.10–8.87; p < 0.001). Exploratory subgroup analysis showed the clipping-coiling difference was most pronounced in Graeb 4–7 (18.2% vs. 62.5%; p = 0.008), with no significant differences in remaining categories. However, the treatment × Graeb-category interaction was non-significant (p = 0.066). Conclusions: An IVH Graeb score ≥ 4 independently predicted symptomatic vasospasm after aneurysmal SAH. The treatment-specific divergence observed in the Graeb 4–7 subgroup was exploratory and hypothesis-generating, suggesting that early cerebrospinal fluid diversion may warrant particular consideration when endovascular coiling is performed in patients with moderate IVH.
No takes yet. Share an insight, caveat, or question.
Ko et al. (2026) conducted a cohort in Aneurysmal subarachnoid hemorrhage (n=307). Intraventricular hemorrhage Graeb score ≥ 4 vs. Intraventricular hemorrhage Graeb score < 4 was evaluated on Symptomatic vasospasm (OR 4.32, 95% CI 2.10-8.87, p=<0.001). An intraventricular hemorrhage Graeb score ≥ 4 independently predicted symptomatic vasospasm after aneurysmal subarachnoid hemorrhage (OR 4.32).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: